Literature DB >> 19630804

Platelet hyperreactivity, scavenger receptors and atherothrombosis.

M Valiyaveettil1, E A Podrez.   

Abstract

Scavenger receptors (SRs) were initially identified as macrophage receptors that recognize modified lipoproteins. The lists of SRs, their ligands and cells expressing SRs have been significantly extended during the last two decades. What has become clear is that many ligands of SRs are present in vivo only in pathologic conditions. Several SRs have been identified on platelets with the best studied being scavenger receptors CD36 and SR-BI. Platelet SRs are multiligand receptors with properties of pattern recognition receptors. CD36 and SR-BI are exposed on resting platelets, while other SRs are rapidly expressed upon platelet activation. Thus, platelets may serve as sensors of 'pathologic ligands' in circulation. The role of platelet SRs in platelet physiology is still poorly understood. However, the data are accumulating that SR ligands, present in the circulation under pathologic conditions, interact with platelet SR and modulate platelet reactivity, thereby contributing to thrombosis and cardiovascular pathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630804      PMCID: PMC2857393          DOI: 10.1111/j.1538-7836.2009.03422.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  29 in total

1.  Specific oxidized phospholipids inhibit scavenger receptor bi-mediated selective uptake of cholesteryl esters.

Authors:  Mohammad Z Ashraf; Niladri S Kar; Xi Chen; Jaewoo Choi; Robert G Salomon; Maria Febbraio; Eugene A Podrez
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

2.  Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A.

Authors:  Suzanne J A Korporaal; Miranda Van Eck; Jelle Adelmeijer; Martin Ijsseldijk; Ruud Out; Ton Lisman; Peter J Lenting; Theo J C Van Berkel; Jan-Willem N Akkerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-30       Impact factor: 8.311

3.  Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI.

Authors:  Manojkumar Valiyaveettil; Niladri Kar; Mohammad Z Ashraf; Tatiana V Byzova; Maria Febbraio; Eugene A Podrez
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

4.  Influence of PDZK1 on lipoprotein metabolism and atherosclerosis.

Authors:  Olivier Kocher; Ayce Yesilaltay; Ching-Hung Shen; Songwen Zhang; Kathleen Daniels; Rinku Pal; Jianzhu Chen; Monty Krieger
Journal:  Biochim Biophys Acta       Date:  2008-03-10

5.  A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein.

Authors:  Kan Chen; Maria Febbraio; Wei Li; Roy L Silverstein
Journal:  Circ Res       Date:  2008-05-22       Impact factor: 17.367

6.  Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice.

Authors:  Arunima Ghosh; Wei Li; Maria Febbraio; Ricardo G Espinola; Keith R McCrae; Erin Cockrell; Roy L Silverstein
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

7.  Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice.

Authors:  Vandana S Dole; Jana Matuskova; Eliza Vasile; Ayce Yesilaltay; Wolfgang Bergmeier; Michael Bernimoulin; Denisa D Wagner; Monty Krieger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04-24       Impact factor: 8.311

8.  Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling.

Authors:  Muhammad R Marwali; Chang-Ping Hu; Bhavna Mohandas; Abhijit Dandapat; Prabhakar Deonikar; Jiawei Chen; Ian Cawich; Tatsuya Sawamura; Mahendra Kavdia; Jawahar L Mehta
Journal:  J Pharmacol Exp Ther       Date:  2007-05-30       Impact factor: 4.030

9.  Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36.

Authors:  Niladri S Kar; Mohammad Z Ashraf; Manojkumar Valiyaveettil; Eugene A Podrez
Journal:  J Biol Chem       Date:  2008-02-01       Impact factor: 5.157

10.  CD36 is a receptor for oxidized high density lipoprotein: implications for the development of atherosclerosis.

Authors:  Rick F Thorne; Nizar M Mhaidat; Kylie J Ralston; Gordon F Burns
Journal:  FEBS Lett       Date:  2007-02-28       Impact factor: 4.124

View more
  10 in total

Review 1.  Anti-oxidant properties of high-density lipoprotein and atherosclerosis.

Authors:  Eugene A Podrez
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-03-30       Impact factor: 2.557

Review 2.  Regulation of platelet function by class B scavenger receptors in hyperlipidemia.

Authors:  Alejandro Zimman; Eugene A Podrez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

Review 3.  High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease.

Authors:  Meliana Riwanto; Ulf Landmesser
Journal:  J Lipid Res       Date:  2013-07-20       Impact factor: 5.922

4.  Human platelets efficiently kill IgG-opsonized E. coli.

Authors:  Anum H Riaz; Brian E Tasma; Michael E Woodman; R Mark Wooten; Randall G Worth
Journal:  FEMS Immunol Med Microbiol       Date:  2012-03-20

5.  Redistribution and hemostatic action of recombinant activated factor VII associated with platelets.

Authors:  Irene Lopez-Vilchez; Ulla Hedner; Carmen Altisent; Maribel Diaz-Ricart; Gines Escolar; Ana M Galan
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

6.  Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression.

Authors:  Lisa Pasterk; Sandra Lemesch; Bettina Leber; Markus Trieb; Sanja Curcic; Vanessa Stadlbauer; Rufina Schuligoi; Rudolf Schicho; Akos Heinemann; Gunther Marsche
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

7.  Editorial: Platelets as Players in Neuropathologies: Novel Diagnostic and Therapeutic Targets.

Authors:  Samuel C Wassmer; Christian Humpel; Jacqueline M Orian
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

Review 8.  Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell.

Authors:  Alessandro Morotti; Cristina Barale; Elena Melchionda; Isabella Russo
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

Review 9.  Antiplatelet Effects of PCSK9 Inhibitors in Primary Hypercholesterolemia.

Authors:  Piotr Pęczek; Mateusz Leśniewski; Tomasz Mazurek; Lukasz Szarpak; Krzysztof J Filipiak; Aleksandra Gąsecka
Journal:  Life (Basel)       Date:  2021-05-23

10.  Hyperoxidized Albumin Modulates Platelets and Promotes Inflammation Through CD36 Receptor in Severe Alcoholic Hepatitis.

Authors:  Adil Bhat; Sukanta Das; Gaurav Yadav; Sudrishti Chaudhary; Ashish Vyas; Mojahidul Islam; Abhishak C Gupta; Meenu Bajpai; Rakhi Maiwall; Jaswinder Singh Maras; Shiv K Sarin
Journal:  Hepatol Commun       Date:  2019-11-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.